Serum lipoprotein(a) profiles in a Singaporean poplulation

Pathology

Volumn 31, Issue 3, 1999, Pages 225-229

  Wong, Moh Sim ^a   Chew, William L S ^b   Aw, Tar Choon ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b ALEXANDRA HOSPITAL   (Singapore)

Author keywords

Cholesterol; Coronary heart disease; Ethnic variation; Lipoprotein(a)

Indexed keywords

LIPOPROTEIN A;

ADULT; ARTICLE; CHINESE; CORONARY RISK; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INDIAN; LIPOPROTEIN BLOOD LEVEL; MALAYSIA; MALE; MORTALITY; NORMAL HUMAN; POPULATION RESEARCH; RACE DIFFERENCE; SEX DIFFERENCE; SINGAPORE;

EID: 0041150246     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/003130299105034     Document Type: Article

References (48)

1. 1. Beglehole R. International trends in coronary heart disease mortality, morbidity and risk factors. Epidemiol Rev 1990; 12: 1-15.
2. 2. 1996 Health Facts Singapore. Health Statistics Section, Policy and Planning Department, Ministry of Health, Singapore.
3. 3. Berg K. A new serum type system in man: the Lp(a) system. Acta Pathol Microbiol Scand 1963; 59: 369.
4. 4. Glueck CJ, Tracy T, Sieve-Smith L, Wang P. Whether, to what degree and why lipoprotein(a) levels change. Clin Chim Acta 1995; 238(1): 11-9.
5. 5. Scanu Am, Fless GM. Lipoprotein(a): heterogeneity and biological significance. J Clin Invest 1990; 85: 1709-15.
6. 6. Scanu AM. Lipoprotein (a): a genetic risk factor for premature coronary heart disease. J Am Med Assoc 1993; 267: 3326-9.
7. 7. Klezovitch O, Scanu AM. Heterogeneity of lipoprotein(a): growing complexities. Curr Opin Lipidol 1995; 6: 223-8.
8. 8. Smith EB, Cochran S. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein: preferential immobilisation of lipoprotein(a) [Lp(a)]. Atherosclerosis 1990; 84: 173-81.
9. 9. Pepin JM, O'Neill JA, Hoff HA. Quantitation of apo(a) and apoB in human atherosclerotic lesions. J Lipid Res 1991; 32: 317-27.
10. 10. Haberland ME, Fless GM. Malondaldehyde modification of lipoprotein(a) produces avid human uptake by human monocyte macrophages. J Biol Chem 1992; 267: 4143-51.
11. 11. Cremer P, Nagel D, Labrot B, et al. Lipoprotein(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 1994; 24: 444-53.
12. 12. Bostom AG, Cupples LA, Jenner JL, et al. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. J Am Med Assoc 1996; 276(7): 544-8.
13. 13. Lun KC, Lee HP. Standardised mortality ratios for some selected causes among the main ethnic and Chinese dialect groups in Singapore, 1970. Singapore Med J 1981; 22(3) 144-9.
14. 14. Danaraj TJ, Acker MS, Danaraj W, et al. Ethnic groups differences in coronary heart disease in Singapore: an analysis of necropsy records. Am Heart J 1959; 58: 516-26.
15. 15. Chao TC. Pre-hospital deaths due to ischaemic heart diseases in Singapore. Singapore Med J 1973; 14: 294-7.
16. 16. Assman G, Schulte H, von Eckardstein A. Hypertriglyceridaemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996; 77(14): 1179-8.
17. 17. Yla-Herttuala S. Biochemistry of the arterial wall in developing atherosclerosis. Ann NY Acad Sci 1991; 623: 40-59.
18. 18. Nago N, Kayaba K, Hiraoka J, et al. Lipoprotein(a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors. Am J Epidemiol 1995; 141(9): 815-21.
19. 19. Qin S, Wang S, Li C. Apolipoprotein(a) polymorphism in relation to coronary heart disease in Chinese Han nationality. Chung Hua Hsueh Tsa Chih 1995; 75(10): 588-91.
20. 20. Sandholzer C, Hallman DM, Saha N, et al. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 1991; 86: 607-14.
21. 21. Yamamoto H, Imazu M, Yamabe T, et al. Risk factors for restenosis after percutaneous transluminal coronary angioplasty: role of lipoprotein(a). Am Heart J 1996; 130(6): 1168-73.
22. 22. Enas EA, Mehta J. Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention and therapy. Coronary Artery Disease in Asian Indians (CADI) Study. Clin Cardiol 1995; 18(3): 131-5.
23. 23. Thomas I, Gupta S, Sempos C, Cooper R. Serum lipids of Indian physicians living in the US compared to US-born physicians. Atherosclerosis 1986; 61: 99-106.
24. 24. Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. Br Med J 1991; 302: 560-4.
25. 25. Derry CW, Bourne DE, Sayed AR, et al. Variations in mortality of the coloured, white, and Asian population groups in the RSA, 1978-1982. IV. Ischaemic heart disease. S Afr Med J 1987; 72: 698-700.
26. 26. Tunstall-Pedoe H, Clayton D, Morris JN, et al. Coronary heart attacks in east London. Lancet 1975; ii: 833-8.
27. 27. Mohan V, Deepa R, Haranath SP, et al. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India. Diabetes Care 1998; 21(11): 1819-23.
28. 28. Sethi SK, Tan HL, ESC Koay, Aw TC. Lipid and lipoprotein reference ranges in Asian newborns. Proc ACB Nat Meet 1997; 38.
29. 29. DeMeester CA, Bu X, Gray RJ, et al. Genetic variation in lipoprotein (a) in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein(a) gene locus. Am J Hum Genet 1995; 56(1): 287-93.
30. 30. Craig W, Poulin S, Bostom A, et al. Further characterisation of the plasma lipoprotein(a) distribution. J Clin Lab Anal 1995; 9(6): 392-6.
31. 31. Bhatnagar D, Anand IS, Durrington PN, et al. Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet 1995; 435(8947): 405-9.
32. 32. Campbell B, Tate J, Lepre F, Hickman P. Lipoprotein(a): biology, clinical utility and measurement. Clin Biochem Rev 1992; 13: 55-9.
33. 33. Aro A, Jauhiainen M, Partanen R, et al. Stearic acid, trans fatty acids and dairy fats: Effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a) and lipid transfer proteins in healthy subjects. Am J Clin Nutr 1997; 65(5): 1419-26.
34. 34. Sonnichsen AC, Richter WO, Schwandt P. Reduction of lipoprotein(a) by weight loss. Int J Obesity 1990; 14: 487-94.
35. 35. Pandolfi C, Pelligrinin L, Dede A, Lo Vecchio Mercantini F. Lipoprotein(a), parameters of lipid metabolism and hemostasis in obese patients. Minerva Endocrinol 1997; 22(1): 13-7.
36. 36. Hughes K, Yeo PPB, Lun KC, et al. Cardiovascular diseases in Chinese, Malays and Indians in Singapore. Differences in risk factor levels. J Epidemiol Comm Health 1990; 44: 29-33.
37. 37. Mackness MI, Bhathagar D, Weiringa G, et al. A comparative study of 6 commercial lipoprotein(a) assays in 17 laboratories within the British isles. Ann Clin Biochem 1996; 33: 63-70.
38. 38. Laker MF, Evans K. Analysis of apolipoproteins. Ann Clin Biochem 1996; 33(1): 5-22.
39. 39. Tate JR, Rifai N, Berg K, et al. International Federation of Clinical Chemistry standardisation project for the measurement of lipoprotein(a). Phase I. Evaluation of the analytical performance of lipoprotein(a) assay systems and commercial calibrators. Clin Chem 1998; 44(8): 1629-40.
40. 40. Ledue TB, Neveux LM, Palomaki GE, et al. The relationship between serum levels of lipoprotein(A) and proteins associated with the acute phase response. Clin Chim Acta 1993; 223: 73-82.
41. 41. Min WK, Huh JW, Low JO. The effect of acute phase status on lipoprotein(a) concentration. Clin Chem 1997; 43(6): S267.
42. 42. Maher VM, Brown BG, Marvocina SM, et al. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). Am Med Assoc 1995; 274(22): 1771-4.
43. 43. Thompson GR, Maher WM, Matthews S, et al. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density lipoprotein apharesis. Lancet 1995; 345(8953): 811-6.
44. 44. Klausen IC, Hausen PS, Povlsen JV, et al. A unique pattern of apo(a) polymorphism in an isolaed east Greenlandi Inuit (Eskimo) population. Eur J Epidemiol 1995; 11(5): 563-8.
45. 45. Leino A, Impivaara O, Kaitsaari M, Jarvisalo J. Serum concentrations of apolipoprotein A-1, apolipoprotein B and lipoprotein(a) in a population sample. Clin Chem 1995; 41(11): 1633-6.
46. 46. Csaszar A. Apolipoprotein polymorphism in Hungary. Acta Biomed Ateneo Parmense 1995; 66(3-4): 169-74.
47. 47. Jungner I, Mendis S, Bjellerup P. Lipoprotein(a) levels in a Swedish population in relation to other lipid parameters and in comparison with a male Sri Lankan population. Clin Biochem 1995; 28(4): 427-34.
48. 48. Orem A, Deger O, Onder E, et al. Distribution of serum lipoprotein(a) concentrations in a healthy Turkish population. Ann Clin Biochem 1994; 31: 343-6.